Top Stories

Grifols consolidates position among world’s most sustainable biotech companies after improving rating in Dow Jones Best-in-Class indices

TOPICS:
Grifols

Posted By: The Corner 5th May 2026

Alphavalue/Divacons | The Catalan company specialising in blood products has consolidated its position among the world’s most sustainable biotech companies after improving its rating in the Dow Jones Best-in-Class indices. With a score of 74 points – four more than the previous year – the firm has now been listed for five consecutive years on the World index and six on the Europe index. Grifols: Buy, Target Price €14.3 per share.

About the Author

The Corner
The Corner has a team of on-the-ground reporters in capital cities ranging from New York to Beijing. Their stories are edited by the teams at the Spanish magazine Consejeros (for members of companies’ boards of directors) and at the stock market news site Consenso Del Mercado (market consensus). They have worked in economics and communication for over 25 years.